Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: EMPA-KIDNEY

SMC accepts Boehringer/Lilly’s Jardiance for CKD within NHS Scotland

SMC accepts Boehringer/Lilly’s Jardiance for CKD within NHS Scotland
p p Read More

The serious, progressive kidney disease affects nearly 850 million people worldwide

July 9, 2024 Boehringer Ingelheim, chronic kidney disease, EMPA-KIDNEY, empagliflozin, Jardiance, News, NHS Scotland, Scottish Medicines Consortium
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy